June 18, 2025 - 22:31

In a recent discussion, financial analysts Kenny Polcari and Jack Manley examined the implications of the Federal Reserve's decision to maintain current interest rates. This move is seen as a pivotal moment for investors, particularly in the technology sector. With interest rates remaining stable, there is a renewed optimism surrounding tech stocks, which have historically shown resilience and growth potential.
Polcari emphasized that the tech industry is poised for a strong performance, driven by ongoing innovations and increased demand for digital solutions. Manley echoed this sentiment, noting that the Fed's decision could lead to a favorable investment climate, enabling tech companies to thrive. As businesses increasingly adopt advanced technologies, investors are encouraged to consider the long-term benefits of engaging with this dynamic sector.
The panelists concluded that while market fluctuations are inevitable, the fundamentals of technology-driven companies suggest a promising outlook for investors willing to navigate the evolving landscape.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...